You are here

indianpharmanetwork's blog

Blinatumomab Medicine - Injection in India

The drug Blinatumomab is a bispecific CD19-directed CD3 T-cell engager that binds to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells. It activates endogenous T cells by connecting CD3 in the T-cell receptor (TCR) complex with CD19 on benign and malignant B cells. Blinatumomab Medicine is used in treating patients who have relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children.

Subscribe to RSS - indianpharmanetwork's blog